BeStock  
Stocks › Biotechnology › NVCT

Nuvectis Pharma NVCT

US equityMarket cap rank #3422Biotechnology
$19.39 −$0.45 (-2.27%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $19.39 0.00%
Open$19.60
Prev close$19.84
Day range$19.02 – $20.18
Volume301.6K
Market cap$666.80M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership34.2%-4.47 pts vs. prior quarter
Institutions holding114+9 vs. prior quarter
Insider trades (recent)42 buys / 1 sellsNet buying
Short interest7.80% of floatDays to cover 15.2 · as of 30 Oct 2026
Short-sale volume share32.4%5-day average of daily volume

Short-sale volume as % of daily volume

13%23%33%42%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$476.3K (9 inflow days, 11 outflow days).

Net flow by order size, last 20 sessions

−$346.1KSuper−$130.1KBig−$211.4KMid−$163.3KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 35.3% of shares outstanding.

Largest holders

  • Ron Bentsur10.73%
  • Charles Mosseri-Marlio9.58%
  • Enrique Poradosu5.25%
  • Shay Shemesh5.21%
  • Tang Capital Management, LLC4.51%
  • Soleus Capital Management, L.P.4.36%
  • BlackRock3.80%
  • Perceptive Advisors LLC2.91%

By investor type

  • Individual/Insider33.09%
  • Mutual Fund20.47%
  • Hedge Fund8.68%
  • VC/PE Fund3.63%
  • Private Company0.90%
  • Public Company0.19%
  • Government Pension Fund0.16%
  • Insurance Company0.12%

Reported short interest has risen from 5.64% to 7.80% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
BlackRock Mutual Fund 2026/Q3 +305,690 3.8%
State Street Global Advisors Mutual Fund 2026/Q3 +120,797 1.1%
FMR Mutual Fund 2026/Q3 +104,156 0.3%
Invesco Capital Management LLC Mutual Fund 2026/Q3 +79,904 0.2%
Geode Capital Management, LLC Mutual Fund 2026/Q3 +71,095 1.5%
UBS Asset Management Mutual Fund 2026/Q3 +56,422 0.4%
Soleus Capital Management, L.P. Hedge Fund 2026/Q3 +498,024 4.4%
Soleus Capital LLC VC/PE Fund 2026/Q3 +150,000 0.4%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +40,823 0.1%
Tang Capital Management, LLC Mutual Fund 2026/Q3 +1,550,000 4.5%
Perceptive Advisors LLC VC/PE Fund 2026/Q3 +1,000,000 2.9%
Sphera Funds Management Ltd Hedge Fund 2026/Q3 +382,945 1.1%
Alyeska Investment Group, L.P. Hedge Fund 2026/Q3 +275,000 0.8%
BlackRock Mutual Fund 2026/Q3 +236,844 3.1%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +225,315 3.1%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
2 Aug 2026 Michael Carson Officer Other Acquisition +30,000 – 230,118
29 Jun 2026 Ron Bentsur Chairperson & CEO Open Market Acquisition +12,500 $20.00 3,688,424
29 Jun 2026 Charles Mosseri-Marlio Open Market Acquisition +50,000 $18.32 3,295,897
10 Jun 2026 James Oliviero Independent Director Other Acquisition +35,000 – 122,828
10 Jun 2026 Matthew Kaplan Independent Director Other Acquisition +35,000 – 159,760
10 Jun 2026 Juan Sanchez Independent Director Other Acquisition +35,000 – 113,795
10 Jun 2026 Kenneth Hoberman Independent Director Other Acquisition +35,000 – 168,140
5 Jan 2026 Ron Bentsur Chairperson & CEO Other Acquisition +150,000 – 3,605,924
5 Jan 2026 Enrique Poradosu Co-Founder, Executive VP, Chief Scientific & Business Officer Other Acquisition +150,000 – 1,767,986
5 Jan 2026 Michael Carson Officer Other Acquisition +61,200 – 200,118
5 Jan 2026 Shay Shemesh Co-Founder, Executive VP, Chief Development & Operations Officer Other Acquisition +150,000 – 1,754,735
4 Nov 2025 Ron Bentsur Chairperson & CEO Open Market Acquisition +5,000 $5.72 3,455,924
4 Nov 2025 Matthew Kaplan Independent Director Open Market Acquisition +11,000 $5.84 124,760
4 Nov 2025 Juan Sanchez Independent Director Open Market Acquisition +13,000 $5.79 78,565
26 Oct 2025 Charles Mosseri-Marlio Open Market Acquisition +154,770 $6.28 3,245,897
21 Sep 2025 Juan Sanchez Independent Director Other Acquisition +30,000 – 65,565
21 Sep 2025 Juan Sanchez Independent Director Initial Statement of Beneficial +0 – 35,565
19 Jun 2025 Charles Mosseri-Marlio Open Market Acquisition +5,603 $7.99 3,091,127
17 Jun 2025 Charles Mosseri-Marlio Open Market Acquisition +33,442 $8.11 2,976,203
11 Jun 2025 James Oliviero Independent Director Other Acquisition +30,000 – 87,828

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 2,544,952 7.8% 15.2
15 Oct 2026 2,400,867 7.4% 13.9
30 Sep 2026 2,522,106 7.7% 10.3
15 Sep 2026 2,362,527 7.2% 14.8
31 Aug 2026 2,196,224 6.7% 9.3
14 Aug 2026 1,836,385 5.6% 9.2

Discussion

No comments yet — be the first to weigh in on NVCT.

Sign in to join the discussion.

Scroll to Top